Literature DB >> 10525406

Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel.

R C Moore1, I Y Lee, G L Silverman, P M Harrison, R Strome, C Heinrich, A Karunaratne, S H Pasternak, M A Chishti, Y Liang, P Mastrangelo, K Wang, A F Smit, S Katamine, G A Carlson, F E Cohen, S B Prusiner, D W Melton, P Tremblay, L E Hood, D Westaway.   

Abstract

The novel locus Prnd is 16 kb downstream of the mouse prion protein (PrP) gene Prnp and encodes a 179 residue PrP-like protein designated doppel (Dpl). Prnd generates major transcripts of 1.7 and 2.7 kb as well as some unusual chimeric transcripts generated by intergenic splicing with Prnp. Like PrP, Dpl mRNA is expressed during embryogenesis but, in contrast to PrP, it is expressed minimally in the CNS. Unexpectedly, Dpl is upregulated in the CNS of two PrP-deficient (Prnp(0/0)) lines of mice, both of which develop late-onset ataxia, suggesting that Dpl may provoke neurodegeneration. Dpl is the first PrP-like protein to be described in mammals, and since Dpl seems to cause neurodegeneration similar to PrP, the linked expression of the Prnp and Prnd genes may play a previously unrecognized role in the pathogenesis of prion diseases or other illnesses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525406     DOI: 10.1006/jmbi.1999.3108

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  145 in total

1.  A statistical view of genome transcription?

Authors:  C Finta; P G Zaphiropoulos
Journal:  J Mol Evol       Date:  2001-08       Impact factor: 2.395

2.  Grand ideas floating freely. Conference on the new prion biology: basic science, diagnosis and therapy.

Authors:  Bruce Chesebro
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

3.  Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene.

Authors:  A Li; S Sakaguchi; R Atarashi; B C Roy; R Nakaoke; K Arima; N Okimura; J Kopacek; K Shigematsu
Journal:  Cell Mol Neurobiol       Date:  2000-10       Impact factor: 5.046

Review 4.  Cellular prion protein: implications in seizures and epilepsy.

Authors:  Roger Walz; Rosa Maria R P S Castro; Tonicarlo R Velasco; Carlos G Carlotti; Américo C Sakamoto; Ricardo R Brentani; Vilma R Martins
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

5.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice.

Authors:  S E Lloyd; O N Onwuazor; J A Beck; G Mallinson; M Farrall; P Targonski; J Collinge; E M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

6.  Prion infection impairs the cellular response to oxidative stress.

Authors:  O Milhavet; H E McMahon; W Rachidi; N Nishida; S Katamine; A Mangé; M Arlotto; D Casanova; J Riondel; A Favier; S Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 7.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

8.  Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia.

Authors:  Eckhard Flechsig; Ivan Hegyi; Rainer Leimeroth; Armando Zuniga; Daniela Rossi; Antonio Cozzio; Petra Schwarz; Thomas Rülicke; Jürgen Götz; Adriano Aguzzi; Charles Weissmann
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

9.  Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation.

Authors:  Manuel Sánchez-Alavez; Bruno Conti; Gianluca Moroncini; José R Criado
Journal:  Brain Res       Date:  2007-05-22       Impact factor: 3.252

10.  Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.

Authors:  Taslim A Al-Hilal; Seung Woo Chung; Jeong Uk Choi; Farzana Alam; Jooho Park; Seong Who Kim; Sang Yoon Kim; Fakhrul Ahsan; In-San Kim; Youngro Byun
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.